Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
4
FDA:4
Drug Approvals
Clinical Trials
No trials found
News
Alzinova Secures Funding for Phase II Alzheimer's Drug Trial Preparations
• Alzinova has successfully raised capital to advance preparations for Phase II clinical trials of its Alzheimer's disease therapeutic candidate, following promising early-stage results. • The company is now fully focused on Phase II trial preparations, as highlighted in Carnegie's commissioned research reports and confirmed in Alzinova's Q1 review. • This development represents a significant milestone in Alzinova's clinical pipeline, potentially offering a new approach to addressing the unmet needs in Alzheimer's disease treatment.